Latest On TG Therapeutics, Inc (TGTX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-06 07:44 EST | News | TG Therapeutics' Stock Surge: Exploring The Factors And Exercising Caution (Rating Upgrade) | N/A |  |
| 2023-05-02 02:37 EST | News | TG Therapeutics jumps 19% to hit 52-week high after Q1 beat (update) | N/A | |
| 2023-05-01 14:23 EST | News | TG Therapeutics GAAP EPS of -$0.28 beats by $0.07, revenue of $7.8M beats by $4.42M | N/A | |
| 2023-05-01 14:23 EST | News | TG Therapeutics slips despite Q1 beat | N/A | |
| 2023-05-01 14:22 EST | News | TG Therapeutics, Inc. (TGTX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-04-29 00:22 EST | News | TG Therapeutics: A Plethora Of Good News, Strong Revenues Expected | N/A | |
| 2023-04-27 23:34 EST | News | TG Therapeutics gains after reimbursement win for multiple sclerosis therapy | N/A | |
| 2023-04-11 19:18 EST | News | TG Therapeutics extends rally to hit 52-week high after B. Riley comments | N/A | |
| 2023-04-11 19:18 EST | News | Hot Stocks: TLRY drops on earnings; MARA, MSTR, RIOT, COIN boosted by crypto rise; PSMT gains; MRNA falls | N/A | |
| 2023-04-11 04:01 EST | News | TG Therapeutics jumps 22% as Cantor cites strong Briumvi sales | N/A | |
| 2023-03-31 11:03 EST | News | TG Therapeutics' multiple sclerosis drug Briumvi gets EMA panel backing | N/A | |
| 2023-03-22 17:59 EST | News | TG Therapeutics' Briumvi Has Potential For Growth In A Crowded Market | N/A | |
| 2023-03-20 19:43 EST | News | TG Therapeutics: That ICER Report Doesn't Bother Me | N/A | |
| 2023-03-09 23:16 EST | News | TG Therapeutics’ price for multiple sclerosis therapy is not low enough - ICER | N/A | |
| 2023-03-01 01:53 EST | News | TG Therapeutics, Inc. (TGTX) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-28 10:24 EST | News | TG Therapeutics GAAP EPS of -$0.39 misses by $0.14, revenue of $0.08M misses by $1.52M | N/A | |
| 2023-02-27 20:17 EST | News | TG Therapeutics Q4 2022 Earnings Preview | N/A | |
| 2023-02-23 20:12 EST | News | TG Therapeutics' Briumvi: A Tough Sell For Multiple Sclerosis Treatment Market | N/A | |
| 2023-02-07 11:09 EST | News | TG Therapeutics up as Cantor sees a “strong launch” for multiple sclerosis therapy | N/A | |
| 2023-02-01 21:47 EST | News | TG Therapeutics: Strategy After Briumvi Launch | N/A | |
| 2023-01-26 12:41 EST | News | TG Therapeutics launches newly approved multiple sclerosis therapy | N/A | |
| 2023-01-11 14:59 EST | News | TG Therapeutics adds 10% to extend gains after insider purchase | N/A | |
| 2023-01-02 17:51 EST | News | TG Therapeutics: Ramifications Of Briumvi Approval | N/A | |
| 2022-12-29 23:50 EST | News | TG Therapeutics surges as focus turns to launch of new multiple sclerosis therapy | N/A | |
| 2022-12-28 18:27 EST | News | TG Therapeutics jumps 19% as FDA approves multiple sclerosis therapy | N/A | |
| 2022-12-24 22:09 EST | News | Stocks To Watch: Nio, Tesla And Hopes For A Santa Clause Rally | N/A | |
| 2022-12-17 21:07 EST | News | It's almost 2023, but here are the drugs the FDA could approve before the end of the year | N/A | |
| 2022-12-15 16:42 EST | News | TG Therapeutics: Ublituximab Could Achieve $1 Billion In Annual Sales By Year-End 2024 | N/A | |
| 2022-12-14 23:31 EST | News | TG Therapeutics: Would Santa Deliver An Early Present? | N/A | |
| 2022-11-13 05:29 EST | News | TG Therapeutics (TGTX) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-10 23:59 EST | News | TG Therapeutics GAAP EPS of -$0.26 beats by $0.07, revenue of $0.09M misses by $1.61M | N/A | |
| 2022-11-10 23:59 EST | News | TG Therapeutics jumps 56% amid FDA labeling talks for multiple sclerosis therapy | N/A | |
| 2022-10-09 13:35 EST | News | TG Therapeutics: Elucidating The Upcoming Binary | N/A | |
| 2022-09-21 15:15 EST | News | TG Therapeutics: We Are Just Hanging In There | N/A | |
| 2022-08-25 19:03 EST | News | TG Therapeutics announces peer-reviewed publication of multiple sclerosis phase 3 trials | N/A | |
| 2022-08-09 08:40 EST | News | TG Therapeutics stock soars 18% on Q2 beat as net loss narrows; eyes MS drug win by year-end | N/A | |
| 2022-08-09 08:40 EST | News | TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-08 09:01 EST | News | TG Therapeutics GAAP EPS of -$0.30 beats by $0.17, revenue of $0.6M beats by $0.42M | N/A | |
| 2022-08-06 00:27 EST | News | TG Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-07-09 02:04 EST | News | TG Therapeutics And Ublituximab: From Icing To Lifeline | N/A | |
| 2022-06-01 21:32 EST | News | TG Therapeutics slips as FDA withdraws approval for cancer drug | N/A | |
| 2022-05-31 12:26 EST | News | TG Therapeutics announces delay in FDA review for multiple sclerosis drug | N/A | |
| 2022-05-21 18:22 EST | News | TG Therapeutics initiated at BofA with a bearish view on multiple sclerosis drug | N/A | |
| 2022-04-22 18:32 EST | News | TG Therapeutics: Can The Company Successfully Turn Around? | N/A | |
| 2022-04-18 21:06 EST | News | TG Therapeutics: I May Double Down Again | N/A | |
| 2022-04-18 21:06 EST | News | TG Therapeutics extends losses as H.C. Wainwright slashes target on Ukoniq setback | N/A | |
| 2022-04-18 06:43 EST | News | TG Therapeutics stock falls 24% as it withdraws Ukoniq from sale, pulls filing with FDA | N/A | |
| 2022-03-03 18:32 EST | News | TG Therapeutics stock falls as FDA extends review of blood cancer drug combo | N/A | |
| 2022-03-01 13:48 EST | News | TG Therapeutics GAAP EPS of -$0.70 misses by $0.08, revenue of $2.32M beats by $0.08M | N/A | |
| 2022-03-01 13:47 EST | News | TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q4 2021 Results - Earnings Call Transcript | N/A | |
About TG Therapeutics, Inc (TGTX):
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. The company is headquartered in New York, New York.
General
- Name TG Therapeutics, Inc
- Symbol TGTX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 272
- Last Split Factor100:5625
- Last Split Date2012-04-30
- Fiscal Year EndDecember
- IPO Date1995-12-14
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.tgtherapeutics.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 36580.51
- Price/Book (Most Recent Quarter) 13.05
- Enterprise Value Revenue 40882.96
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.06
- Next Year EPS Estimate -$0.80
- Next Quarter EPS Estimate -$0.50
- Operating Margin -179996%
- Return on Assets -43%
- Return on Equity -100%
- Revenue 152000
- Earnings Per Share -$1.96
- Revenue Per Share $0
- Gross Profit 152000
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 6.47 billion
- EBITDA -158616992
- PE Ratio 37.85
- Analyst Target Price $75.33
- Book Value Per Share $4.00
View More
Share Statistics
- Shares Outstanding 137.81 million
- Shares Float 120.36 million
- % Held by Insiders 713%
- % Held by Institutions 67.24%
- Shares Short 11.84 million
- Shares Short Prior Month 11.76 million
- Short Ratio 8
- Short % of Float 10%
- Short % of Shares Outstanding 8%
View More
Technicals
- Beta 2.13
- 52 Week High $56.74
- 52 Week Low $7.12
- 50 Day Moving Average 46.97
- 200 Day Moving Average 37.82
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
TG Therapeutics, Inc (TGTX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
TG Therapeutics, Inc (TGTX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-01 | $38000 | -$0.72 | -$0.58 | -23.78% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.73 | -$0.41 | -76.76% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.47 | -$0.34 | -39.05% |
| 2020-03-31 | 2020-05-11 | $38000 | -$0.48 | -$0.36 | -34.08% |
| 2019-12-31 | 2020-03-02 | $38000 | -$0.44 | -$0.42 | -5.39% |
| 2019-09-30 | 2019-11-12 | $38000 | -$0.69 | -$0.34 | -104.44% |
| 2019-06-30 | 2019-08-09 | $38000 | -$0.42 | -$0.44 | 4.55% |
| 2019-03-31 | 2019-05-10 | $38000 | -$0.43 | -$0.44 | 1.15% |
| 2018-12-31 | 2019-03-01 | $38000 | -$0.69 | -$0.44 | -55.41% |
| 2018-09-30 | 2018-11-09 | $38000 | -$0.43 | -$0.54 | 20.37% |
| 2018-06-30 | 2018-08-07 | $38000 | -$0.59 | -$0.53 | -12.38% |
| 2018-03-31 | 2018-05-08 | $38000 | -$0.59 | -$0.44 | -34.09% |
| 2017-12-31 | 2018-03-08 | $38000 | -$0.46 | -$0.44 | -4.14% |
| 2017-09-30 | 2017-11-08 | $38000 | -$0.48 | -$0.43 | -11.63% |
| 2017-06-30 | 2017-08-09 | $38000 | -$0.45 | -$0.43 | -5.26% |
| 2017-03-31 | 2017-05-05 | $38000 | -$0.52 | -$0.41 | -27.45% |
| 2016-12-31 | 2017-03-10 | $38000 | -$0.48 | -$0.36 | -33.33% |
| 2016-09-30 | 2016-11-07 | $38000 | -$0.50 | -$0.31 | -61.29% |
| 2016-06-30 | 2016-08-08 | $38000 | -$0.33 | -$0.29 | -15.79% |
| 2016-03-31 | 2016-05-10 | $38000 | -$0.28 | -$0.36 | 21.5% |
| 2015-12-31 | 2016-03-07 | $38000 | -$0.37 | -$0.32 | -16.83% |
| 2015-09-30 | 2015-11-09 | $38000 | -$0.28 | -$0.34 | 17.65% |
| 2015-06-30 | 2015-08-10 | $38000 | -$0.38 | -$0.30 | -26.67% |
| 2015-03-31 | 2015-05-04 | $38000 | -$0.39 | -$0.33 | -18.18% |
| 2014-12-31 | 2015-03-11 | $38000 | -$0.48 | -$0.26 | -84.62% |
| 2014-09-30 | 2014-11-10 | $38000 | -$0.51 | -$0.32 | -59.38% |
| 2014-06-30 | 2014-07-21 | $38000 | -$0.32 | -$0.24 | -33.33% |
| 2014-03-31 | 2014-05-12 | $38000 | -$0.25 | -$0.18 | -38.89% |
| 2013-12-31 | 2014-03-05 | $38000 | -$0.19 | -$0.17 | -11.76% |
| 2013-09-30 | 2013-11-11 | $38000 | -$0.16 | -$0.22 | 27.27% |
| 2013-06-30 | 2013-08-01 | $38000 | -$0.29 | -$0.16 | -81.25% |
| 2013-03-31 | 2013-05-14 | $38000 | -$0.17 | -$0.15 | -13.33% |
| 2012-12-31 | 2013-03-12 | $19000 | -$0.12 | -$0.13 | 7.69% |
| 2012-09-30 | 2012-11-08 | $N/A | -$0.16 | -$0.12 | -33.33% |
| 2012-06-30 | 2012-08-09 | $N/A | -$0.16 | -$0.06 | -166.67% |
| 2012-03-31 | 2012-05-21 | $N/A | -$2.03 | ||
| 2011-09-30 | 2011-11-14 | $N/A | -$9.05 | ||
| 2011-06-30 | 2011-08-15 | $N/A | -$64.63 | ||
| 2011-03-31 | 2011-05-23 | $N/A | $84.58 | ||
| 2010-12-31 | 2011-03-02 | $N/A | $9.18 | ||
| 2010-09-30 | 2010-11-15 | $N/A | $0.96 | ||
| 2010-06-30 | 2010-08-16 | $N/A | $43.21 | ||
| 2010-03-31 | 2010-05-24 | $N/A | -$54.27 | ||
| 2009-12-31 | 2010-03-03 | $N/A | -$8.88 | ||
| 2009-09-30 | 2009-11-16 | $N/A | -$16.57 | ||
| 2009-06-30 | 2009-08-14 | $N/A | -$55.45 | ||
| 2009-03-31 | 2009-05-19 | $N/A | -$30.34 | ||
| 2008-12-31 | 2009-02-25 | $N/A | $5.06 | ||
| 2008-09-30 | 2008-12-03 | $N/A | -$55.53 | ||
| 2008-06-30 | 2008-08-19 | $N/A | -$56.64 | ||
| 2008-03-31 | 2008-05-20 | $N/A | -$62.10 | ||
| 2007-09-30 | 2007-11-14 | $N/A | -$112.50 | -$28.12 | -300.07% |
| 2007-06-30 | 2007-07-09 | $N/A | -$112.50 | -$84.37 | -33.34% |
| 2007-03-31 | 2007-05-15 | $N/A | -$119.73 | ||
| 2006-09-30 | 2006-11-14 | $N/A | -$84.37 | -$84.37 | 0% |
| 2006-06-30 | 2006-08-14 | $N/A | -$112.50 | -$112.50 | 0% |
| 2006-03-31 | 2006-05-15 | $N/A | -$140.62 | -$140.62 | 0% |
| 2005-09-30 | 2005-09-30 | $N/A | -$118.85 | ||
| 2005-06-30 | 2005-06-30 | $N/A | -$934.25 | ||
| 2005-03-31 | 2005-03-31 | $N/A | -$152.43 | ||
| 2004-12-31 | 2004-12-31 | $N/A | -$196.87 | ||
| 2004-09-30 | 2004-09-30 | $N/A | -$240.39 | ||
| 2004-06-30 | 2004-06-30 | $N/A | -$109.61 | ||
| 2004-03-31 | 2004-03-31 | $N/A | -$140.65 | ||
| 2003-12-31 | 2003-12-31 | $N/A | -$225.00 | ||
| 2003-09-30 | 2003-09-30 | $N/A | -$391.61 | ||
| 2003-06-30 | 2003-06-30 | $N/A | -$93.46 | ||
| 2003-03-31 | 2003-03-31 | $N/A | -$91.67 | ||
| 2002-09-30 | 2002-09-30 | $N/A | -$507.41 | ||
| 2002-06-30 | 2002-06-30 | $N/A | $24.21 | ||
| 2002-03-31 | 2002-03-31 | $N/A | -$552.10 | ||
| 2001-09-30 | 2001-09-30 | $N/A | -$1,528.45 | ||
| 2001-06-30 | 2001-06-30 | $-2712000 | -$4,513.55 | ||
| 2001-03-31 | 2001-03-31 | $2.71 million | $1,855.58 | ||
| 2000-09-30 | 2000-09-30 | $1.07 million | -$2,621.34 | ||
| 2000-06-30 | 2000-06-30 | $1.44 million | -$7,888.48 | ||
| 2000-03-31 | 2000-03-31 | $925000 | -$5,766.57 | ||
| 1999-09-30 | 1999-09-30 | -$986.48 | |||
| 1999-06-30 | 1999-06-30 | -$1,929.43 | |||
| 1999-03-31 | 1999-03-31 | -$2,666.06 | |||
| 1998-09-30 | 1998-09-30 | -$5,140.91 | |||
| 1998-06-30 | 1998-06-30 | $695.14 | |||
| 1998-03-31 | 1998-03-31 | -$9,885.89 |
TG Therapeutics, Inc (TGTX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
TG Therapeutics, Inc (TGTX) Chart:
TG Therapeutics, Inc (TGTX) News:
Below you will find a list of latest news for TG Therapeutics, Inc (TGTX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
TG Therapeutics, Inc (TGTX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 15 | 0 | CALL | 0 | 0 | 140.07 | TRUE | 0 | 0 |
| 2026-05-15 | 20 | 14.25 | CALL | 0 | 383 | 0 | TRUE | 0 | 0 |
| 2026-05-15 | 23 | 0 | CALL | 0 | 303 | 91.53 | TRUE | 0 | 0 |
| 2026-05-15 | 24 | 0 | CALL | 0 | 148 | 0 | TRUE | 0 | 0 |
| 2026-05-15 | 25 | 9.62 | CALL | 30 | 504 | 81.24 | TRUE | 9.62 | 0 |
| 2026-05-15 | 26 | 8.7 | CALL | 1 | 329 | 78.69 | TRUE | 8.7 | 0 |
| 2026-05-15 | 27 | 0 | CALL | 0 | 36 | 49.64 | TRUE | 0 | 0 |
| 2026-05-15 | 28 | 0 | CALL | 0 | 130 | 52.36 | TRUE | 0 | 0 |
| 2026-05-15 | 29 | 6.1 | CALL | 0 | 131 | 56.67 | TRUE | 0 | 0 |
| 2026-05-15 | 30 | 5.42 | CALL | 0 | 887 | 62.82 | TRUE | 0 | 0 |
| 2026-05-15 | 31 | 4.1 | CALL | 1 | 474 | 53.43 | TRUE | 4.1 | 0 |
| 2026-05-15 | 32 | 3.8 | CALL | 19 | 973 | 65.07 | TRUE | -0.4 | -0.1 |
| 2026-05-15 | 33 | 3.1 | CALL | 60 | 258 | 61.92 | TRUE | -0.13 | -0.04 |
| 2026-05-15 | 34 | 2.56 | CALL | 0 | 321 | 59.93 | TRUE | 0 | 0 |
| 2026-05-15 | 35 | 1.88 | CALL | 174 | 2418 | 55.74 | FALSE | -0.21 | -0.1 |
| 2026-05-15 | 36 | 1.65 | CALL | 0 | 794 | 57.97 | FALSE | 0 | 0 |
| 2026-05-15 | 37 | 1.05 | CALL | 5 | 863 | 52.44 | FALSE | -0.25 | -0.19 |
| 2026-05-15 | 38 | 0.99 | CALL | 54 | 465 | 58.36 | FALSE | 0.04 | 0.04 |
| 2026-05-15 | 39 | 0 | CALL | 0 | 193 | 56.92 | FALSE | 0 | 0 |
| 2026-05-15 | 40 | 0.55 | CALL | 3 | 1218 | 56.83 | FALSE | 0 | 0 |
| 2026-05-15 | 41 | 0.45 | CALL | 0 | 75 | 59.4 | FALSE | 0 | 0 |
| 2026-05-15 | 42 | 0.35 | CALL | 1 | 142 | 58.88 | FALSE | 0.35 | 0 |
| 2026-05-15 | 45 | 0.19 | CALL | 14 | 867 | 62.43 | FALSE | -0.09 | -0.32 |
| 2026-05-15 | 50 | 0 | CALL | 0 | 395 | 71.14 | FALSE | 0 | 0 |
| 2026-05-15 | 55 | 0 | CALL | 0 | 479 | 144.4 | FALSE | 0 | 0 |
| 2026-05-15 | 15 | 0.16 | PUT | 0 | 13 | 264.16 | FALSE | 0 | 0 |
| 2026-05-15 | 20 | 0.15 | PUT | 0 | 488 | 128.33 | FALSE | 0 | 0 |
| 2026-05-15 | 23 | 0 | PUT | 0 | 58 | 95.73 | FALSE | 0 | 0 |
| 2026-05-15 | 24 | 0 | PUT | 0 | 95 | 87.39 | FALSE | 0 | 0 |
| 2026-05-15 | 25 | 0 | PUT | 0 | 218 | 81.37 | FALSE | 0 | 0 |
| 2026-05-15 | 26 | 0 | PUT | 0 | 185 | 78.65 | FALSE | 0 | 0 |
| 2026-05-15 | 27 | 0 | PUT | 0 | 3859 | 71.98 | FALSE | 0 | 0 |
| 2026-05-15 | 28 | 0.5 | PUT | 0 | 3769 | 70.35 | FALSE | 0 | 0 |
| 2026-05-15 | 29 | 0.6 | PUT | 2 | 3283 | 67.31 | FALSE | 0.6 | 0 |
| 2026-05-15 | 30 | 0.8 | PUT | 0 | 1532 | 64.11 | FALSE | 0 | 0 |
| 2026-05-15 | 31 | 0 | PUT | 0 | 156 | 62.24 | FALSE | 0 | 0 |
| 2026-05-15 | 32 | 1.32 | PUT | 16 | 105 | 62.4 | FALSE | 0.06 | 0.05 |
| 2026-05-15 | 33 | 0 | PUT | 0 | 27 | 58.24 | FALSE | 0 | 0 |
| 2026-05-15 | 34 | 2 | PUT | 16 | 26 | 57.1 | FALSE | 2 | 0 |
| 2026-05-15 | 35 | 2.4 | PUT | 50 | 86 | 53.48 | TRUE | -0.1 | -0.04 |
| 2026-05-15 | 36 | 2.75 | PUT | 4 | 38 | 55.8 | TRUE | 2.75 | 0 |
| 2026-05-15 | 37 | 3.41 | PUT | 1 | 20 | 45.26 | TRUE | 3.41 | 0 |
| 2026-05-15 | 38 | 0 | PUT | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2026-05-15 | 39 | 0 | PUT | 0 | 16 | 0 | TRUE | 0 | 0 |
| 2026-05-15 | 40 | 0 | PUT | 0 | 26 | 0 | TRUE | 0 | 0 |
| 2026-05-15 | 41 | 0 | PUT | 0 | 0 | 50.65 | TRUE | 0 | 0 |
| 2026-05-15 | 42 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-05-15 | 45 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-05-15 | 50 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-05-15 | 55 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 26 | 0 | CALL | 0 | 0 | 87.51 | TRUE | 0 | 0 |
| 2026-06-18 | 27 | 0 | CALL | 0 | 0 | 68.73 | TRUE | 0 | 0 |
| 2026-06-18 | 28 | 0 | CALL | 0 | 0 | 67.14 | TRUE | 0 | 0 |
| 2026-06-18 | 29 | 0 | CALL | 0 | 0 | 63.65 | TRUE | 0 | 0 |
| 2026-06-18 | 30 | 0 | CALL | 0 | 0 | 60.86 | TRUE | 0 | 0 |
| 2026-06-18 | 31 | 0 | CALL | 0 | 0 | 59.58 | TRUE | 0 | 0 |
| 2026-06-18 | 32 | 0 | CALL | 0 | 0 | 62.34 | TRUE | 0 | 0 |
| 2026-06-18 | 33 | 0 | CALL | 0 | 0 | 55.66 | TRUE | 0 | 0 |
| 2026-06-18 | 34 | 0 | CALL | 0 | 0 | 65.55 | TRUE | 0 | 0 |
| 2026-06-18 | 35 | 0 | CALL | 0 | 0 | 58.39 | FALSE | 0 | 0 |
| 2026-06-18 | 36 | 0 | CALL | 0 | 0 | 57.13 | FALSE | 0 | 0 |
| 2026-06-18 | 37 | 0 | CALL | 0 | 0 | 60.42 | FALSE | 0 | 0 |
| 2026-06-18 | 38 | 0 | CALL | 0 | 0 | 50.71 | FALSE | 0 | 0 |
| 2026-06-18 | 39 | 0 | CALL | 0 | 0 | 53.92 | FALSE | 0 | 0 |
| 2026-06-18 | 40 | 0 | CALL | 0 | 0 | 54.15 | FALSE | 0 | 0 |
| 2026-06-18 | 41 | 0 | CALL | 0 | 0 | 54.24 | FALSE | 0 | 0 |
| 2026-06-18 | 42 | 0 | CALL | 0 | 0 | 49.38 | FALSE | 0 | 0 |
| 2026-06-18 | 26 | 0 | PUT | 0 | 0 | 93.93 | FALSE | 0 | 0 |
| 2026-06-18 | 27 | 0 | PUT | 0 | 0 | 81.54 | FALSE | 0 | 0 |
| 2026-06-18 | 28 | 0 | PUT | 0 | 0 | 74.68 | FALSE | 0 | 0 |
| 2026-06-18 | 29 | 0 | PUT | 0 | 0 | 68.44 | FALSE | 0 | 0 |
| 2026-06-18 | 30 | 0 | PUT | 0 | 0 | 58.81 | FALSE | 0 | 0 |
| 2026-06-18 | 31 | 0 | PUT | 0 | 0 | 67.45 | FALSE | 0 | 0 |
| 2026-06-18 | 32 | 0 | PUT | 0 | 0 | 60.26 | FALSE | 0 | 0 |
| 2026-06-18 | 33 | 0 | PUT | 0 | 0 | 54.67 | FALSE | 0 | 0 |
| 2026-06-18 | 34 | 0 | PUT | 0 | 0 | 53.46 | FALSE | 0 | 0 |
| 2026-06-18 | 35 | 0 | PUT | 0 | 0 | 51.82 | TRUE | 0 | 0 |
| 2026-06-18 | 36 | 0 | PUT | 0 | 0 | 51.03 | TRUE | 0 | 0 |
| 2026-06-18 | 37 | 0 | PUT | 0 | 0 | 50.21 | TRUE | 0 | 0 |
| 2026-06-18 | 38 | 0 | PUT | 0 | 0 | 52.69 | TRUE | 0 | 0 |
| 2026-06-18 | 39 | 0 | PUT | 0 | 0 | 49.1 | TRUE | 0 | 0 |
| 2026-06-18 | 40 | 0 | PUT | 0 | 0 | 49.52 | TRUE | 0 | 0 |
| 2026-06-18 | 41 | 0 | PUT | 0 | 0 | 46.73 | TRUE | 0 | 0 |
| 2026-06-18 | 42 | 0 | PUT | 0 | 0 | 46.52 | TRUE | 0 | 0 |
| 2026-08-21 | 15 | 0 | CALL | 0 | 272 | 88.32 | TRUE | 0 | 0 |
| 2026-08-21 | 20 | 0 | CALL | 0 | 27 | 75.72 | TRUE | 0 | 0 |
| 2026-08-21 | 21 | 0 | CALL | 0 | 0 | 84.96 | TRUE | 0 | 0 |
| 2026-08-21 | 22 | 0 | CALL | 0 | 104 | 73.33 | TRUE | 0 | 0 |
| 2026-08-21 | 23 | 0 | CALL | 0 | 8 | 70.19 | TRUE | 0 | 0 |
| 2026-08-21 | 24 | 0 | CALL | 0 | 2 | 52.41 | TRUE | 0 | 0 |
| 2026-08-21 | 25 | 0 | CALL | 0 | 24 | 69.95 | TRUE | 0 | 0 |
| 2026-08-21 | 26 | 0 | CALL | 0 | 151 | 66.11 | TRUE | 0 | 0 |
| 2026-08-21 | 27 | 0 | CALL | 0 | 49 | 64.02 | TRUE | 0 | 0 |
| 2026-08-21 | 28 | 8.21 | CALL | 0 | 37 | 61.66 | TRUE | 0 | 0 |
| 2026-08-21 | 29 | 7.75 | CALL | 0 | 50 | 62.96 | TRUE | 0 | 0 |
| 2026-08-21 | 30 | 0 | CALL | 0 | 58 | 59.17 | TRUE | 0 | 0 |
| 2026-08-21 | 31 | 0 | CALL | 0 | 16 | 66.47 | TRUE | 0 | 0 |
| 2026-08-21 | 32 | 0 | CALL | 0 | 51 | 60.61 | TRUE | 0 | 0 |
| 2026-08-21 | 33 | 0 | CALL | 0 | 16 | 58.61 | TRUE | 0 | 0 |
| 2026-08-21 | 34 | 0 | CALL | 0 | 21 | 55.65 | TRUE | 0 | 0 |
| 2026-08-21 | 35 | 4.5 | CALL | 15 | 424 | 57.37 | FALSE | -0.37 | -0.08 |
| 2026-08-21 | 36 | 0 | CALL | 0 | 44 | 54.92 | FALSE | 0 | 0 |
| 2026-08-21 | 37 | 3.56 | CALL | 0 | 92 | 53.96 | FALSE | 0 | 0 |
| 2026-08-21 | 38 | 2.88 | CALL | 0 | 14 | 42.83 | FALSE | 0 | 0 |
| 2026-08-21 | 39 | 2.4 | CALL | 0 | 23 | 53.34 | FALSE | 0 | 0 |
| 2026-08-21 | 40 | 2.44 | CALL | 0 | 376 | 52.15 | FALSE | 0 | 0 |
| 2026-08-21 | 45 | 1.4 | CALL | 3 | 491 | 53.2 | FALSE | 0.07 | 0.05 |
| 2026-08-21 | 50 | 0 | CALL | 0 | 0 | 53.62 | FALSE | 0 | 0 |
| 2026-08-21 | 15 | 0 | PUT | 0 | 78 | 89.38 | FALSE | 0 | 0 |
| 2026-08-21 | 20 | 0 | PUT | 0 | 78 | 79.25 | FALSE | 0 | 0 |
| 2026-08-21 | 21 | 0 | PUT | 0 | 10 | 73.66 | FALSE | 0 | 0 |
| 2026-08-21 | 22 | 0 | PUT | 0 | 15 | 69.06 | FALSE | 0 | 0 |
| 2026-08-21 | 23 | 0 | PUT | 0 | 8 | 70.52 | FALSE | 0 | 0 |
| 2026-08-21 | 24 | 0 | PUT | 0 | 27 | 53.98 | FALSE | 0 | 0 |
| 2026-08-21 | 25 | 0 | PUT | 0 | 6 | 58.83 | FALSE | 0 | 0 |
| 2026-08-21 | 26 | 0 | PUT | 0 | 13 | 49.32 | FALSE | 0 | 0 |
| 2026-08-21 | 27 | 0 | PUT | 0 | 21 | 60.57 | FALSE | 0 | 0 |
| 2026-08-21 | 28 | 0 | PUT | 0 | 60 | 46.17 | FALSE | 0 | 0 |
| 2026-08-21 | 29 | 0 | PUT | 0 | 16 | 59.91 | FALSE | 0 | 0 |
| 2026-08-21 | 30 | 0 | PUT | 0 | 48 | 43.49 | FALSE | 0 | 0 |
| 2026-08-21 | 31 | 3.14 | PUT | 0 | 19 | 44.19 | FALSE | 0 | 0 |
| 2026-08-21 | 32 | 0 | PUT | 0 | 1 | 56 | FALSE | 0 | 0 |
| 2026-08-21 | 33 | 3.4 | PUT | 1 | 12 | 53.29 | FALSE | 3.4 | 0 |
| 2026-08-21 | 34 | 0 | PUT | 0 | 5 | 53.09 | FALSE | 0 | 0 |
| 2026-08-21 | 35 | 4.6 | PUT | 0 | 44 | 52.44 | TRUE | 0 | 0 |
| 2026-08-21 | 36 | 0 | PUT | 0 | 0 | 51.96 | TRUE | 0 | 0 |
| 2026-08-21 | 37 | 0 | PUT | 0 | 0 | 41.66 | TRUE | 0 | 0 |
| 2026-08-21 | 38 | 0 | PUT | 0 | 0 | 40.09 | TRUE | 0 | 0 |
| 2026-08-21 | 39 | 0 | PUT | 0 | 25 | 48.51 | TRUE | 0 | 0 |
| 2026-08-21 | 40 | 0 | PUT | 0 | 0 | 50.84 | TRUE | 0 | 0 |
| 2026-08-21 | 45 | 0 | PUT | 0 | 0 | 45.77 | TRUE | 0 | 0 |
| 2026-08-21 | 50 | 0 | PUT | 0 | 0 | 44.88 | TRUE | 0 | 0 |
| 2026-11-20 | 20 | 0 | CALL | 0 | 2 | 72.21 | TRUE | 0 | 0 |
| 2026-11-20 | 22 | 0 | CALL | 0 | 0 | 67.63 | TRUE | 0 | 0 |
| 2026-11-20 | 23 | 0 | CALL | 0 | 0 | 69.39 | TRUE | 0 | 0 |
| 2026-11-20 | 24 | 0 | CALL | 0 | 0 | 63.47 | TRUE | 0 | 0 |
| 2026-11-20 | 25 | 0 | CALL | 0 | 0 | 66.68 | TRUE | 0 | 0 |
| 2026-11-20 | 26 | 0 | CALL | 0 | 0 | 62.98 | TRUE | 0 | 0 |
| 2026-11-20 | 27 | 0 | CALL | 0 | 0 | 59.97 | TRUE | 0 | 0 |
| 2026-11-20 | 28 | 0 | CALL | 0 | 0 | 66.05 | TRUE | 0 | 0 |
| 2026-11-20 | 29 | 0 | CALL | 0 | 20 | 59.09 | TRUE | 0 | 0 |
| 2026-11-20 | 30 | 0 | CALL | 0 | 0 | 60.73 | TRUE | 0 | 0 |
| 2026-11-20 | 31 | 0 | CALL | 0 | 0 | 57.66 | TRUE | 0 | 0 |
| 2026-11-20 | 32 | 0 | CALL | 0 | 0 | 59.18 | TRUE | 0 | 0 |
| 2026-11-20 | 33 | 0 | CALL | 0 | 0 | 55.79 | TRUE | 0 | 0 |
| 2026-11-20 | 34 | 0 | CALL | 0 | 3 | 54.77 | TRUE | 0 | 0 |
| 2026-11-20 | 35 | 5.85 | CALL | 0 | 13 | 57.41 | FALSE | 0 | 0 |
| 2026-11-20 | 36 | 0 | CALL | 0 | 0 | 55.43 | FALSE | 0 | 0 |
| 2026-11-20 | 37 | 5 | CALL | 0 | 21 | 53.73 | FALSE | 0 | 0 |
| 2026-11-20 | 38 | 0 | CALL | 0 | 0 | 48.27 | FALSE | 0 | 0 |
| 2026-11-20 | 39 | 0 | CALL | 0 | 0 | 54.9 | FALSE | 0 | 0 |
| 2026-11-20 | 40 | 3.8 | CALL | 75 | 8 | 52.56 | FALSE | -0.2 | -0.05 |
| 2026-11-20 | 45 | 0 | CALL | 0 | 30 | 54.62 | FALSE | 0 | 0 |
| 2026-11-20 | 50 | 1.65 | CALL | 0 | 62 | 63.07 | FALSE | 0 | 0 |
| 2026-11-20 | 20 | 0 | PUT | 0 | 2 | 79.02 | FALSE | 0 | 0 |
| 2026-11-20 | 22 | 0 | PUT | 0 | 0 | 55.15 | FALSE | 0 | 0 |
| 2026-11-20 | 23 | 0 | PUT | 0 | 0 | 65.47 | FALSE | 0 | 0 |
| 2026-11-20 | 24 | 0 | PUT | 0 | 0 | 67.14 | FALSE | 0 | 0 |
| 2026-11-20 | 25 | 0 | PUT | 0 | 0 | 47.04 | FALSE | 0 | 0 |
| 2026-11-20 | 26 | 0 | PUT | 0 | 0 | 48.32 | FALSE | 0 | 0 |
| 2026-11-20 | 27 | 0 | PUT | 0 | 0 | 63.08 | FALSE | 0 | 0 |
| 2026-11-20 | 28 | 0 | PUT | 0 | 0 | 55.83 | FALSE | 0 | 0 |
| 2026-11-20 | 29 | 0 | PUT | 0 | 3 | 56.8 | FALSE | 0 | 0 |
| 2026-11-20 | 30 | 0 | PUT | 0 | 0 | 53.72 | FALSE | 0 | 0 |
| 2026-11-20 | 31 | 0 | PUT | 0 | 0 | 52.16 | FALSE | 0 | 0 |
| 2026-11-20 | 32 | 0 | PUT | 0 | 0 | 52.46 | FALSE | 0 | 0 |
| 2026-11-20 | 33 | 0 | PUT | 0 | 0 | 45.42 | FALSE | 0 | 0 |
| 2026-11-20 | 34 | 0 | PUT | 0 | 0 | 53.1 | FALSE | 0 | 0 |
| 2026-11-20 | 35 | 0 | PUT | 0 | 0 | 52.98 | TRUE | 0 | 0 |
| 2026-11-20 | 36 | 0 | PUT | 0 | 0 | 52.12 | TRUE | 0 | 0 |
| 2026-11-20 | 37 | 0 | PUT | 0 | 0 | 50.54 | TRUE | 0 | 0 |
| 2026-11-20 | 38 | 0 | PUT | 0 | 0 | 51.09 | TRUE | 0 | 0 |
| 2026-11-20 | 39 | 0 | PUT | 0 | 0 | 50.93 | TRUE | 0 | 0 |
| 2026-11-20 | 40 | 0 | PUT | 0 | 0 | 45.17 | TRUE | 0 | 0 |
| 2026-11-20 | 45 | 0 | PUT | 0 | 0 | 47.49 | TRUE | 0 | 0 |
| 2026-11-20 | 50 | 0 | PUT | 0 | 0 | 44.91 | TRUE | 0 | 0 |
| 2027-01-15 | 13 | 0 | CALL | 0 | 187 | 74.54 | TRUE | 0 | 0 |
| 2027-01-15 | 15 | 20.67 | CALL | 0 | 797 | 84.46 | TRUE | 0 | 0 |
| 2027-01-15 | 18 | 0 | CALL | 0 | 224 | 70.74 | TRUE | 0 | 0 |
| 2027-01-15 | 20 | 16.4 | CALL | 0 | 967 | 65.65 | TRUE | 0 | 0 |
| 2027-01-15 | 22 | 14.75 | CALL | 0 | 4167 | 69.19 | TRUE | 0 | 0 |
| 2027-01-15 | 25 | 12.25 | CALL | 2 | 739 | 60.23 | TRUE | 12.25 | 0 |
| 2027-01-15 | 27 | 0 | CALL | 0 | 369 | 62.15 | TRUE | 0 | 0 |
| 2027-01-15 | 30 | 9.05 | CALL | 36 | 849 | 56.75 | TRUE | -0.45 | -0.05 |
| 2027-01-15 | 32 | 0 | CALL | 0 | 241 | 60.35 | TRUE | 0 | 0 |
| 2027-01-15 | 35 | 6.9 | CALL | 0 | 3280 | 58.34 | FALSE | 0 | 0 |
| 2027-01-15 | 37 | 5.7 | CALL | 0 | 757 | 56.2 | FALSE | 0 | 0 |
| 2027-01-15 | 40 | 4.85 | CALL | 0 | 2050 | 54.77 | FALSE | 0 | 0 |
| 2027-01-15 | 42 | 4 | CALL | 0 | 105 | 53.61 | FALSE | 0 | 0 |
| 2027-01-15 | 45 | 0 | CALL | 0 | 1167 | 47.78 | FALSE | 0 | 0 |
| 2027-01-15 | 47 | 3.1 | CALL | 0 | 250 | 49.53 | FALSE | 0 | 0 |
| 2027-01-15 | 50 | 2.2 | CALL | 0 | 895 | 52.21 | FALSE | 0 | 0 |
| 2027-01-15 | 55 | 0 | CALL | 0 | 238 | 50.87 | FALSE | 0 | 0 |
| 2027-01-15 | 60 | 0.85 | CALL | 1 | 1673 | 47.62 | FALSE | -0.15 | -0.15 |
| 2027-01-15 | 13 | 0 | PUT | 0 | 55 | 106.92 | FALSE | 0 | 0 |
| 2027-01-15 | 15 | 0 | PUT | 0 | 211 | 76.66 | FALSE | 0 | 0 |
| 2027-01-15 | 18 | 0 | PUT | 0 | 87 | 65.12 | FALSE | 0 | 0 |
| 2027-01-15 | 20 | 0 | PUT | 0 | 181 | 66.38 | FALSE | 0 | 0 |
| 2027-01-15 | 22 | 0 | PUT | 0 | 330 | 63.16 | FALSE | 0 | 0 |
| 2027-01-15 | 25 | 2.43 | PUT | 0 | 2248 | 61.02 | FALSE | 0 | 0 |
| 2027-01-15 | 27 | 0 | PUT | 0 | 122 | 58.83 | FALSE | 0 | 0 |
| 2027-01-15 | 30 | 4.11 | PUT | 0 | 540 | 56.97 | FALSE | 0 | 0 |
| 2027-01-15 | 32 | 0 | PUT | 0 | 25 | 56.25 | FALSE | 0 | 0 |
| 2027-01-15 | 35 | 0 | PUT | 0 | 1711 | 53.66 | TRUE | 0 | 0 |
| 2027-01-15 | 37 | 0 | PUT | 0 | 14 | 53.58 | TRUE | 0 | 0 |
| 2027-01-15 | 40 | 0 | PUT | 0 | 184 | 46.47 | TRUE | 0 | 0 |
| 2027-01-15 | 42 | 0 | PUT | 0 | 172 | 51.86 | TRUE | 0 | 0 |
| 2027-01-15 | 45 | 13.45 | PUT | 0 | 287 | 50.78 | TRUE | 0 | 0 |
| 2027-01-15 | 47 | 0 | PUT | 0 | 0 | 48.8 | TRUE | 0 | 0 |
| 2027-01-15 | 50 | 0 | PUT | 0 | 1035 | 49.7 | TRUE | 0 | 0 |
| 2027-01-15 | 55 | 0 | PUT | 0 | 69 | 44.09 | TRUE | 0 | 0 |
| 2027-01-15 | 60 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2028-01-21 | 15 | 22.1 | CALL | 0 | 749 | 73.46 | TRUE | 0 | 0 |
| 2028-01-21 | 20 | 0 | CALL | 0 | 125 | 68.77 | TRUE | 0 | 0 |
| 2028-01-21 | 23 | 0 | CALL | 0 | 135 | 66.11 | TRUE | 0 | 0 |
| 2028-01-21 | 25 | 0 | CALL | 0 | 235 | 69.07 | TRUE | 0 | 0 |
| 2028-01-21 | 28 | 0 | CALL | 0 | 22 | 67.51 | TRUE | 0 | 0 |
| 2028-01-21 | 30 | 0 | CALL | 0 | 196 | 62.7 | TRUE | 0 | 0 |
| 2028-01-21 | 32 | 0 | CALL | 0 | 355 | 64.82 | TRUE | 0 | 0 |
| 2028-01-21 | 35 | 0 | CALL | 0 | 67 | 64.48 | FALSE | 0 | 0 |
| 2028-01-21 | 37 | 0 | CALL | 0 | 6 | 55.53 | FALSE | 0 | 0 |
| 2028-01-21 | 40 | 0 | CALL | 0 | 29 | 59.41 | FALSE | 0 | 0 |
| 2028-01-21 | 42 | 8.66 | CALL | 16 | 64 | 57.8 | FALSE | 8.66 | 0 |
| 2028-01-21 | 45 | 7.1 | CALL | 0 | 1101 | 56.44 | FALSE | 0 | 0 |
| 2028-01-21 | 50 | 6.4 | CALL | 50 | 197 | 55.63 | FALSE | 0.1 | 0.02 |
| 2028-01-21 | 55 | 5 | CALL | 0 | 1321 | 52.92 | FALSE | 0 | 0 |
| 2028-01-21 | 15 | 0 | PUT | 0 | 172 | 62.17 | FALSE | 0 | 0 |
| 2028-01-21 | 20 | 0 | PUT | 0 | 48 | 55.95 | FALSE | 0 | 0 |
| 2028-01-21 | 23 | 3.5 | PUT | 15 | 22 | 58.33 | FALSE | 3.5 | 0 |
| 2028-01-21 | 25 | 0 | PUT | 0 | 17 | 61.76 | FALSE | 0 | 0 |
| 2028-01-21 | 28 | 0 | PUT | 0 | 40 | 60.04 | FALSE | 0 | 0 |
| 2028-01-21 | 30 | 0 | PUT | 0 | 365 | 65.43 | FALSE | 0 | 0 |
| 2028-01-21 | 32 | 7.3 | PUT | 29 | 5 | 54.54 | FALSE | 7.3 | 0 |
| 2028-01-21 | 35 | 0 | PUT | 0 | 8 | 57.3 | TRUE | 0 | 0 |
| 2028-01-21 | 37 | 0 | PUT | 0 | 3 | 55.85 | TRUE | 0 | 0 |
| 2028-01-21 | 40 | 0 | PUT | 0 | 20 | 56.04 | TRUE | 0 | 0 |
| 2028-01-21 | 42 | 0 | PUT | 0 | 0 | 55.33 | TRUE | 0 | 0 |
| 2028-01-21 | 45 | 16.01 | PUT | 0 | 117 | 54.52 | TRUE | 0 | 0 |
| 2028-01-21 | 50 | 0 | PUT | 0 | 114 | 52.84 | TRUE | 0 | 0 |
| 2028-01-21 | 55 | 23.14 | PUT | 0 | 2 | 52.7 | TRUE | 0 | 0 |
Latest TGTX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 987 | $4.135 |
| Jun 13, 2022 7:59 PM EST | 93 | $4.14 |
| Jun 13, 2022 7:59 PM EST | 1 | $4.14 |
| Jun 13, 2022 7:59 PM EST | 10 | $4.14 |
| Jun 13, 2022 7:59 PM EST | 200 | $4.135 |
TG Therapeutics, Inc (TGTX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm |
| 2018-07-17 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1001316/000000000018021923/0000000000-18-021923-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000009375119000238/0000093751-19-000238-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000009375120000475/0000093751-20-000475-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000021545719006548/0000215457-19-006548-index.htm |
| 2019-06-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000021545719008047/0000215457-19-008047-index.htm |
| 2018-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000031506618001636/0000315066-18-001636-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000031506619001380/0000315066-19-001380-index.htm |
| 2020-06-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000031506620001583/0000315066-20-001583-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000083423720008183/0000834237-20-008183-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000090266419001008/0000902664-19-001008-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000090266420001111/0000902664-20-001111-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000110465920021910/0001104659-20-021910-index.htm |
| 2020-05-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920058131/0001104659-20-058131-index.htm |
| 2020-06-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000110465920072021/0001104659-20-072021-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm |
| 2020-07-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920080593/0001104659-20-080593-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm |
| 2020-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000110465920092406/0001104659-20-092406-index.htm |
| 2020-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm |
| 2019-05-31 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1001316/000114036119010173/0001140361-19-010173-index.htm |
| 2020-05-29 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1001316/000114036120012674/0001140361-20-012674-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000114420419008306/0001144204-19-008306-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000117266118000780/0001172661-18-000780-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000117266119000823/0001172661-19-000823-index.htm |
| 2019-03-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000117266119000927/0001172661-19-000927-index.htm |
| 2020-01-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000117266120000001/0001172661-20-000001-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000117266120000786/0001172661-20-000786-index.htm |
| 2018-06-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1001316/000119312518195773/0001193125-18-195773-index.htm |
| 2018-07-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1001316/000119312518215834/0001193125-18-215834-index.htm |
| 2019-03-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000131924419000034/0001319244-19-000034-index.htm |
| 2020-01-24 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001316/000131924420000018/0001319244-20-000018-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1001316/000155837020001897/0001558370-20-001897-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000155837020001925/0001558370-20-001925-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000155837020002992/0001558370-20-002992-index.htm |
| 2020-03-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1001316/000155837020002997/0001558370-20-002997-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1001316/000155837020004647/0001558370-20-004647-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1001316/000155837020004651/0001558370-20-004651-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000155837020004722/0001558370-20-004722-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000155837020005097/0001558370-20-005097-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001316/000155837020006304/0001558370-20-006304-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000155837020006314/0001558370-20-006314-index.htm |
| 2020-05-14 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1001316/000155837020006630/0001558370-20-006630-index.htm |
| 2020-05-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1001316/000155837020006795/0001558370-20-006795-index.htm |
| 2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000155837020006811/0001558370-20-006811-index.htm |
| 2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000155837020007744/0001558370-20-007744-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001316/000155837020010225/0001558370-20-010225-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000155837020012661/0001558370-20-012661-index.htm |
| 2018-02-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418001025/0001654954-18-001025-index.htm |
| 2018-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418002262/0001654954-18-002262-index.htm |
| 2018-03-15 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1001316/000165495418002638/0001654954-18-002638-index.htm |
| 2018-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418004295/0001654954-18-004295-index.htm |
| 2018-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1001316/000165495418004519/0001654954-18-004519-index.htm |
| 2018-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1001316/000165495418004521/0001654954-18-004521-index.htm |
| 2018-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418004821/0001654954-18-004821-index.htm |
| 2018-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001316/000165495418005046/0001654954-18-005046-index.htm |
| 2018-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418006261/0001654954-18-006261-index.htm |
| 2018-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418006381/0001654954-18-006381-index.htm |
| 2018-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418006609/0001654954-18-006609-index.htm |
| 2018-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418006703/0001654954-18-006703-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm |
| 2018-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418006743/0001654954-18-006743-index.htm |
| 2018-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418006777/0001654954-18-006777-index.htm |
| 2018-06-25 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1001316/000165495418006935/0001654954-18-006935-index.htm |
| 2018-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm |
| 2018-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm |
| 2018-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm |
| 2018-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm |
| 2018-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm |
| 2018-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm |
| 2018-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm |
| 2018-07-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm |
| 2018-07-09 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007460/0001654954-18-007460-index.htm |
| 2018-07-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007816/0001654954-18-007816-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418008559/0001654954-18-008559-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001316/000165495418008750/0001654954-18-008750-index.htm |
| 2018-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418010436/0001654954-18-010436-index.htm |
| 2018-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418011171/0001654954-18-011171-index.htm |
| 2018-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418012263/0001654954-18-012263-index.htm |
| 2018-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001316/000165495418012303/0001654954-18-012303-index.htm |
| 2018-12-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495418013524/0001654954-18-013524-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm |
| 2019-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419000641/0001654954-19-000641-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419002047/0001654954-19-002047-index.htm |
| 2019-02-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1001316/000165495419002091/0001654954-19-002091-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1001316/000165495419002189/0001654954-19-002189-index.htm |
| 2019-03-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1001316/000165495419002274/0001654954-19-002274-index.htm |
| 2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419002276/0001654954-19-002276-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419003766/0001654954-19-003766-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1001316/000165495419005036/0001654954-19-005036-index.htm |
| 2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1001316/000165495419005037/0001654954-19-005037-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419005419/0001654954-19-005419-index.htm |
| 2019-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419005592/0001654954-19-005592-index.htm |
| 2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001316/000165495419005680/0001654954-19-005680-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419007297/0001654954-19-007297-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm |
| 2019-06-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419009109/0001654954-19-009109-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001316/000165495419009176/0001654954-19-009176-index.htm |
| 2019-08-30 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010203/0001654954-19-010203-index.htm |
| 2019-09-05 | RW | Registration Withdrawal Request | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010400/0001654954-19-010400-index.htm |
| 2019-09-05 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010402/0001654954-19-010402-index.htm |
| 2019-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010620/0001654954-19-010620-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm |
| 2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419012023/0001654954-19-012023-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419012611/0001654954-19-012611-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001316/000165495419012751/0001654954-19-012751-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419013703/0001654954-19-013703-index.htm |
| 2019-12-23 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1001316/000165495419014167/0001654954-19-014167-index.htm |
| 2019-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001316/000165495419014209/0001654954-19-014209-index.htm |
| 2018-07-23 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1001316/999999999518001856/9999999995-18-001856-index.htm |
| 2018-04-30 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1001316/999999999718005345/9999999997-18-005345-index.htm |
| 2018-09-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1001316/999999999718007926/9999999997-18-007926-index.htm |
TG Therapeutics, Inc (TGTX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of TG Therapeutics, Inc (TGTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 713%Institutional Ownership: 6724%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-09-17 | WILLIAM JAMES KENNEDY | Director | Buy | 27,048.00 | 102,378.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm | ||
| 2020-06-22 | WILLIAM JAMES KENNEDY | Director | Buy | 15,000.00 | 109,633.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm | ||
| 2018-06-26 | MICHAEL S WEISS | CEO and President | Buy | 1,018,011.00 | 11,648,805.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm | ||
| 2018-06-26 | Kenneth Hoberman | Director | Buy | 15,000.00 | 116,905.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm | ||
| 2018-06-26 | Yann Echelard | Director | Buy | 15,000.00 | 117,068.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm | ||
| 2018-06-26 | Laurence N Charney | Director | Buy | 15,000.00 | 118,949.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm | ||
| 2019-09-17 | DANIEL HUME | Director | Buy | 27,048.00 | 119,507.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm | ||
| 2018-06-26 | MARK SCHOENEBAUM | Director | Buy | 15,000.00 | 125,949.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm | ||
| 2020-09-09 | RA CAPITAL MANAGEMENT, L.P. | 10% Share Holder | Sell | 158,589.00 | 25.81 | 4,092,738.04 | 12,629,868.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm |
| 2019-06-13 | MICHAEL S WEISS | CEO and President | Buy | 1,179,380.00 | 12,828,185.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm | ||
| 2019-06-26 | MICHAEL S WEISS | CEO and President | Buy | 50,000.00 | 7.04 | 351,750.00 | 12,878,185.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm |
| 2020-06-22 | DANIEL HUME | Director | Buy | 15,000.00 | 134,507.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm | ||
| 2019-09-17 | Kenneth Hoberman | Director | Buy | 27,048.00 | 143,953.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm | ||
| 2019-09-17 | Yann Echelard | Director | Buy | 27,048.00 | 144,116.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm | ||
| 2020-06-22 | MICHAEL S WEISS | CEO and President | Buy | 1,556,029.00 | 14,434,214.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm | ||
| 2019-09-17 | Laurence N Charney | Director | Buy | 27,048.00 | 145,997.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm | ||
| 2020-06-22 | Kenneth Hoberman | Director | Buy | 15,000.00 | 158,953.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm | ||
| 2020-06-22 | Yann Echelard | Director | Buy | 15,000.00 | 159,116.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm | ||
| 2020-06-22 | Laurence N Charney | Director | Buy | 15,000.00 | 160,997.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm | ||
| 2019-07-01 | Sean A Power | CFO, Secretary and Treasurer | Sell | 17,654.00 | 8.47 | 149,529.38 | 383,338.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm |
| 2019-01-02 | Sean A Power | CFO, Secretary and Treasurer | Sell | 37,275.00 | 4.13 | 153,945.75 | 400,992.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm |
| 2020-07-16 | Sean A Power | CFO, Secretary and Treasurer | Buy | 50,000.00 | 433,338.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm | ||
| 2018-07-03 | Sean A Power | CFO, Secretary and Treasurer | Sell | 35,000.00 | 13.19 | 461,650.00 | 438,267.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm |
| 2018-07-02 | Sean A Power | CFO, Secretary and Treasurer | Sell | 12,191.00 | 13.26 | 161,652.66 | 473,267.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm |
| 2018-06-14 | WILLIAM JAMES KENNEDY | Director | Sell | 25,071.00 | 13.45 | 337,204.95 | 60,330.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm |
| 2020-07-16 | Sean A Power | CFO, Secretary and Treasurer | Buy | 200,000.00 | 633,338.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm | ||
| 2020-06-22 | Sagar Lonial | Director | Buy | 65,000.00 | 65,000.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm | ||
| 2018-06-26 | WILLIAM JAMES KENNEDY | Director | Buy | 15,000.00 | 75,330.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm | ||
| 2018-06-26 | DANIEL HUME | Director | Buy | 15,000.00 | 92,459.00 | https://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm | ||
| 2020-06-17 | WILLIAM JAMES KENNEDY | Director | Sell | 7,745.00 | 18.27 | 141,501.15 | 94,633.00 | https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm |